AC
Insider buying
Adar1 Capital Management, Llc bought $2K of InMed Pharmaceuticals Inc. (INM) stock
Adar1 Capital Management, Llc, 10% owner of InMed Pharmaceuticals Inc. (INM), bought 1,000 shares of INM stock worth $2K, per an SEC Form 4 filed Jul 17, 2026.
It was an open-market purchase.
The trade happened on Jul 15, 2026, 2 days before it was made public.
INM has moved -14.5% since the trade date, from $1.59 to $1.36 (Oct 9, 2026 close).
- Traded
- Jul 15, 2026
- Disclosed
- Jul 17, 2026
- Filing delay
- 2 days
- Price since
- -14.5%
- Role
- 10% owner
- Source
- SEC Form 4
More INM insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.